Article content continued

Cannabis stocks have been red hot since mid-August, when Canopy Growth Corp. announced a $5 billion investment from Constellation Brands Inc., the biggest deal in the sector to date. The BI Canada Cannabis Competitive Peers index has gained nearly 50 per cent since then, while other stocks have posted even more outsized gains. Tilray Inc. has soared more than 500 per cent since its July IPO. The stock rallied as much as 11 per cent in New York Thursday, pushing its market value past US$10 billion.

Campbell said he prefers smaller companies, which haven’t risen as much as their bigger peers, and is looking for a mix of Canadian and U.S. exposure. The fund’s holdings will include Valens Groworks Corp., Sunniva Inc., C21 Investments Inc., CannTrust Holdings Inc. and Organigram Holdings Inc.

While Campbell acknowledged that pot-stock valuations are “off the charts,” he said there still will be companies that do “phenomenally well.”

“You’ve got to watch that valuation, you’ve got to figure out what’s reasonable and then continue to track it over time and see whether they’re actually proving that they’re working towards those goals or is it sort of a pie-in-the sky dream?” he said. “Because there will be a day when the market wakes up and says, ‘Whoa, hold on. We’re paying way too much for this and the sector all goes down and some of it will never recover.'”

Bloomberg.com